天麻钩藤饮联合齐拉西酮治疗精神分裂症临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R749

基金项目:


Clinical Study on Tianma Gouteng Decoction Combined with Ziprasidone for Schizo⁃ phrenia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察天麻钩藤饮联合齐拉西酮治疗精神分裂症的临床疗效。方法:采用随机数字表法将 80 例首发精神分裂症患者分为对照组与观察组各40 例。对照组给予齐拉西酮治疗,观察组给予天麻钩藤饮联 合齐拉西酮治疗。比较2 组治疗前后蒙特利尔认知评估量表(MoCA) 评分、阳性与阴性症状量表(PANSS)、 生活质量量表(SQLS) 评分、前瞻记忆测试、炎症因子指标[肿瘤坏死因子-α (TNF-α)、白细胞介 素-6(IL-6)、白细胞介素-10(IL-10)],并评估2 组临床疗效及不良反应发生情况。结果:观察组总有效 率高于对照组,差异有统计学意义(P<0.05)。治疗后,2 组PANSS 及SQLS(心理社会、动力和精力、症状 和不良反应) 评分均低于治疗前(P<0.05),MoCA、基于时间前瞻记忆、基于事件前瞻记忆评分高于治疗 前(P<0.05),且观察组治疗后PANSS 评分及SQLS(心理社会、动力和精力、症状和不良反应) 评分均低于 对照组(P<0.05),MoCA、基于时间前瞻记忆、基于事件前瞻记忆评分高于对照组(P<0.05)。治疗后, 2 组TNF-α、IL-6、IL-10 水平低于治疗前(P<0.05),且观察组治疗后炎症因子指标低于对照组(P< 0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:天麻钩藤饮联合齐拉西酮治疗精神分 裂症疗效确切,能有效改善患者认知功能、记忆功能,减轻炎症反应,提高患者生活质量,安全性较高。

    Abstract:

    Abstract: Objective: To observe the clinical effect of the therapy of Tianma Gouteng Decoction combined with Ziprasidone on schizophrenia. Methods:A total of 80 patients with first-episode schizophrenia were divided into the control group and the observation group according to the random number table method,with 40 cases in each group. The control group was treated with Ziprasidone,and the observation group was treated with Tianma Gouteng Decoction combined with Ziprasidone. Before and after treatment, the Montreal Cognitive Assessment (MoCA) scores, Positive and Negative Syndrome Scale (PANSS), Schizophrenia Quality of Life Scale (SQLS) scores,prospective memory test and indexes of inflammatory factors,including tumor necrosis factor-α (TNF-α),interleukin-6 (IL-6) and interleukin-10 (IL-10),were compared between the two groups. The clinical effects and incidence of adverse reactions in the two groups were evaluated in the two groups. Results:The total effective rate in the observation group was higher than that in the control group,the difference being significant (P<0.05). After treatment,the scores of PANSS and SQLS,including aspects of psychosocial,motivation and energy,symptoms,and side effects in the two groups were lower than those before treatment (P<0.05), and the scores of MoCA, time- based prospective memory and event- based prospective memory were higher than those before treatment (P< 0.05);the scores of PANSS and SQLS in the observation group were lower than those in the control group, and the scores of MoCA, time- based prospective memory and event- based prospective memory were higher than those in the control group (P<0.05). After treatment,the levels of TNF-α,IL-6 and IL-10 in the two groups were lower than those before treatment (P<0.05),and the above indexes of inflammatory factors were lower than those in the control group (P<0.05). There was no significant difference being found in the comparison of the incidence of adverse reactions between the two groups (P>0.05). Conclusion:The therapy of Tianma Gouteng Decoction combined with Ziprasidone has a definite curative effect on schizophrenia, which can improve cognitive function and memory function, reduce the inflammatory responses,and enhance the quality of life of patients,with high safety.

    参考文献
    相似文献
    引证文献
引用本文

何娟娟,李默,劳成明.天麻钩藤饮联合齐拉西酮治疗精神分裂症临床研究[J].新中医,2023,55(7):53-57

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-12
  • 出版日期:
文章二维码